AIM2 and rheumatoid arthritis: AIM2 inflammasome activation mediates cellular pyroptosis and releases pro-inflammatory cytokines IL-1β and IL-18, which are involved in the proliferation of synovial cells, the production of inflammatory mediators and the destruction of joint tissues in RA.